Statement
6 Nov 2024
IFPMA-INTERFARMA-FIFARMA statement on the Rio de Janeiro Declaration of the G20 Health Ministers
The innovative pharmaceutical industry, represented by IFPMA, INTERFARMA and FIFARMA reiterates its commitment to the G20 health priorities, reaffirmed in the Rio de Janeiro Declaration.
Read more
Statement
31 Oct 2024
74th WHO Regional Committee for Europe: Harnessing innovation for public health in the WHO European Region 2025-2030
On 31 October 2024 in Copenhagen, Denmark, IFPMA delivered a statement at the 74th WHO Regional Committee for Europe on harnessing innovation for public health in the WHO European Region 2025-2030.
Read more
Statement
31 Oct 2024
74th WHO Regional Committee for Europe: Framework for resilient and sustainable health systems in the WHO European Region
On 31 October 2024 in Copenhagen, Denmark, IFPMA and EFPIA delivered a statement at the 74th Regional Committee for Europe on the framework for resilient and sustainable health systems in the WHO European Region.
Read more
